Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Dafni, Urania, Wolf, Juergen, Wasag, Bartosz ORCID: 0000-0002-3634-7562, Biernat, Wojciech, Finn, Stephen P., Kammler, Roswitha, Tsourti, Zoi, Rabaglio, Manuela, Ruepp, Barbara, Roschitzki-Voser, Heidi, Stahel, Rolf A., Felip, Enriqueta and Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). J. Thorac. Oncol., 14 (6). S. 1086 - 1095. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Smit, Egbert F., Peters, Solange, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Dafni, Urania, Wolf, Juergen, Wasag, Bartosz ORCID: 0000-0002-3634-7562, Biernat, Wojciech, Finn, Stephen, Kammler, Rosita, Tsourti, Zoi, Rabaglio-Poretti, Manuela, Ruepp, Barbara Ursula, Roschitzki-Voser, Heidi, Stahel, Rolf A. and Felip, Enriqueta (2017). A single-arm phase II trial of afatinib in pretreated patients with advanced NSCLC harboring a HER2 mutation: The ETOP NICHE trial. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Sat Oct 16 04:37:57 2021 CEST.